BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3616427)

  • 1. [Activation of solid materials in a medical linear electron accelerator].
    Ewen K; Lauber-Altmann I
    Rontgenblatter; 1987 Jun; 40(6):185-90. PubMed ID: 3616427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation processes in a medical linear accelerator and spatial distribution of activation products.
    Fischer HW; Tabot BE; Poppe B
    Phys Med Biol; 2006 Dec; 51(24):N461-6. PubMed ID: 17148816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced radioactive nuclides of 10-MeV radiotherapy accelerators detected by using a portable HP-Ge survey meter.
    Fujibuchi T; Obara S; Yamaguchi I; Oyama M; Watanabe H; Sakae T; Katoh K
    Radiat Prot Dosimetry; 2012 Jan; 148(2):168-73. PubMed ID: 21317145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutron production from a mobile linear accelerator operating in electron mode for intraoperative radiation therapy.
    Loi G; Dominietto M; Cannillo B; Ciocca M; Krengli M; Mones E; Negri E; Brambilla M
    Phys Med Biol; 2006 Feb; 51(3):695-702. PubMed ID: 16424589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the radioactivity of the pre-dominant gamma emitters in components used at high-energy proton accelerator facilities.
    Numajiri M
    Radiat Prot Dosimetry; 2007; 123(4):417-25. PubMed ID: 17164270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skyshine radiation resulting from 6 MV and 10 MV photon beams from a medical accelerator.
    Elder DH; Harmon JF; Borak TB
    Health Phys; 2010 Jul; 99(1):17-25. PubMed ID: 20539121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A measuring system with a recombination chamber for neutron dosimetry around medical accelerators.
    Golnik N; Kamiński P; Zielczyński M
    Radiat Prot Dosimetry; 2004; 110(1-4):273-6. PubMed ID: 15353658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced radioactivity in CU targets produced by high-energy heavy ions and the corresponding estimated photon dose rates.
    Yashima H; Uwamino Y; Sugita H; Ito S; Nakamura T; Fukumura A
    Radiat Prot Dosimetry; 2004; 112(2):195-208. PubMed ID: 15280565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of activation products to occupational exposure following treatment using high-energy photons in radiotherapy.
    Petrović N; Krestić-Vesović J; Stojanović D; Ciraj-Bjelac O; Lazarević D; Kovacević M
    Radiat Prot Dosimetry; 2011 Jan; 143(1):109-12. PubMed ID: 20947589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and modelling of megavoltage photon beams for contrast-enhanced radiation therapy.
    Robar JL
    Phys Med Biol; 2006 Nov; 51(21):5487-504. PubMed ID: 17047265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the existence of low-energy photons (<150 keV) in the unflattened x-ray beam from an ordinary radiotherapeutic target in a medical linear accelerator.
    Tsechanski A; Krutman Y; Faermann S
    Phys Med Biol; 2005 Dec; 50(23):5629-39. PubMed ID: 16306657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental simulation of A-bomb gamma ray spectra: revisited.
    Pattison JE; Payne LC; Hugtenburg RP; Beddoe AH; Charles MW
    Radiat Prot Dosimetry; 2004; 109(3):175-80. PubMed ID: 15254320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of activation products and induced dose rates in different high-energy medical linear accelerators.
    Fischer HW; Tabot B; Poppe B
    Health Phys; 2008 Mar; 94(3):272-8. PubMed ID: 18301101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health physics aspects of neutron activated components in a linear accelerator.
    Guo S; Ziemer PL
    Health Phys; 2004 May; 86(5 Suppl):S94-S102. PubMed ID: 15069298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shielding design for a laser-accelerated proton therapy system.
    Fan J; Luo W; Fourkal E; Lin T; Li J; Veltchev I; Ma CM
    Phys Med Biol; 2007 Jul; 52(13):3913-30. PubMed ID: 17664585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shielding analysis of the Microtron MT-25 bunker using the MCNP-4C code and NCRP Report 51.
    Casanova AO; López N; Gelen A; Guevara MV; Díaz O; Cimino L; D'Alessandro K; Melo JC
    Radiat Prot Dosimetry; 2004; 109(3):189-95. PubMed ID: 15254322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental determination of peripheral doses for different IMRT techniques delivered by a Siemens linear accelerator.
    Wiezorek T; Voigt A; Metzger N; Georg D; Schwedas M; Salz H; Wendt TG
    Strahlenther Onkol; 2008 Feb; 184(2):73-9. PubMed ID: 18259698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shielding evaluation of a medical linear accelerator vault in preparation for installing a high-dose rate 252Cf remote afterloader.
    Melhus CS; Rivard MJ; Kurkomelis J; Liddle CB; Massé FX
    Radiat Prot Dosimetry; 2005; 113(4):428-37. PubMed ID: 15755770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards an optimum design of a P-MOS radiation detector for use in high-energy medical photon beams and neutron facilities: analysis of activation materials.
    Price RA
    Radiat Prot Dosimetry; 2005; 115(1-4):386-90. PubMed ID: 16381751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of field modifier blocks on the fast photoneutron dose equivalent from two high-energy medical linear accelerators.
    Hashemi SM; Hashemi-Malayeri B; Raisali G; Shokrani P; Sharafi AA; Jafarizadeh M
    Radiat Prot Dosimetry; 2008; 128(3):359-62. PubMed ID: 17875628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.